Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
By S. Turajlic, Hang Xu, K. Litchfield, A. Rowan, T. Chambers, J. López, D. Nicol, T. O'brien, J. Larkin, S. Horswell and 39 more. Cell, 2018
734 citations recorded by the source corpus.
Summary Clear-cell renal cell carcinoma (ccRCC) exhibits a broad range of metastatic phenotypes that have not been systematically studied to date. Here, we analyzed 575 primary and 335 metastatic biopsies across 100 patients with metastatic ccRCC, including two cases sampledat post-mortem. Metastatic competence was afforded by chromosome complexity, and we identify 9p loss as a highly selected event driving metastasis and ccRCC-related mortality (p = 0.0014). Distinct patterns of metastatic dissemination were observed, including rapid progression to multiple tissue sites seeded by primary tumors of monoclonal structure. By contrast, we observed attenuated progression in cases characterized by high primary tumor heterogeneity, with metastatic competence acquired gradually and initial progression to solitary metastasis. Finally, we observed early divergence of primitive ancestral clones and protracted latency of up to two decades as a feature of pancreatic metastases.
Subfields: Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/234df0ec591a2ac93e7b73fe2649e17488dc1a3b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- W. Marston Linehan
- Eric E. Schadt
- A. Robles
- Arul M. Chinnaiyan
- Antonio Colaprico
- Xi Chen
- M. Wiznerowicz
- A. Krek
In Molecular Biology
- Alexey I. Nesvizhskii
- Dmitry Avtonomov
- Andy T. Kong
- W. Marston Linehan
- Eric E. Schadt
- A. Robles
- Bing Zhang
- Arul M. Chinnaiyan
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma (2019, background): “Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.”